Technology Tools for the Rheumatologist

Save

Four years ago, the genesis of this session (technology tools for rheumatologists) was from the frustration of the archaic technologies we have been using in our medical practices (including user hostile EHRs), compared to the rapid advancing pace of the consumer technologies we use at home. So came the struggle to adapt affordable and usable consumer technology products in the office that would save time (or at least be time neutral) and impact patient management.

Is DAS28 and HAQ-DI Headed for the Graveyard?

Save

Dr. Joseph Smolen delivered one of the most elegant and informative talk on rheumatoid arthritis at this ACR’s meeting as a tribute to Dr. Paul Klemperer. Dr. Smolen led us on a journey, and had us feeling content with what we are doing in practice as we walked with him from historical discoveries of RA through new drug development. Then Dr. Smolen did the unthinkable: he made us crash!

ACR 2018 Podcast - Day 1A

Save

Check out the first part of our Day 1 Podcast from ACR 2018 - LISTEN HERE

Several Studies Addressed Treatment of Axial Spondylitis

Save

Monday afternoon's session on the treatment of Axial Spondyloarthritis presented us with a great selection of studies addressing important issues in modern treatment paradigm of AxSpA.

TRIPLE Trial Results

Save

Pegloticase has become an excellent option for management of patients with chronic refractory gout, although treatment may be limited by the development of anti-drug antibodies that lead to loss of serum urate (sUA) lowering effect.

Emerging Trends in the Treatment of Rheumatoid Arthritis

Save

Factors That Contribute to Uveitis in SpA

Save

We know that uveitis is an extra-articular manifestation of SpA but what remains unclear is if there are any factors that may play a role in the development of uveitis. One group sought to understand these issues.

ACR 2018 - Day 1 Report

Save

RheumNow is in Chicago covering the ACR annual meeting. Here are the highlights from Sunday (day one). Be sure to check our complete coverage, including articles, video reports and tweets, at acr18.rheumnow.com.

Gout and the Social Determinants of Health

Save

During a fascinating gout session on October 21, Hyon Choi presented an important paper (abstract 874) which used data from the Health Professionals Follow-up Study to try to understand the rapid increase in the incidence of gout in recent decades.

Because It's Rare Doesn’t Mean It Doesn’t Exist: A Tribute to Relapsing Polychondritis

Save

During medical training, we were taught about rare diseases that are unlikely to be encountered, but there is a reason why our professors even mention these diseases. It is not just for our board exams; the lectures are for us to recognize the features of the disease when the rare patient comes across our exam table.

High Dose Flu Vaccine for Patients Younger Than 65?

Save

We are diving head first into flu season and we need to prepare ourselves. Last year we now know that 80,000 Americans died from influenza.

The Great Debate: Plaquenil - Choosing Safety over Efficacy?

Save

ICI-Induced Inflammatory Arthritis and Shared Epitope Alleles

Save

Immune checkpoint inhibitors (ICI) have changed the hematology/oncology world. However, their AEs from a rheumatologic standpoint are still being evaluated and at this time, genetic risk factors for inflammatory arthritis due to ICI are not well understood. Dr. Cappelli et al evaluated a possible connection with HLA typing at their institution.

The 16th Annual La Paulee

Save

La Paulee is traditionally the party/feast after harvest and a time when hard work is rewarded with food, fun, and wine. And so it was that evening; after better understanding genes, cytokines, and pathology it was time to have a good time with friends, old and new.

Walking the Tightrope of Treat to Target in Psoriatic Arthritis

Save

In the last few years, new studies have been published examining if early intervention and tight control (TC) of psoriatic arthritis (PsA) disease activity will have the same beneficial outcomes as it does for rheumatoid arthritis (RA).  

Nurse Led Gout Management Highly Effective

Save

UK researchers have shown that nurse-led gout management, using a treat-to-target urate-lowering strategy, is efficacious and cost-effective compared with usual physicain care. The results are published in the recent Lancet edition.

RheumNow Week in Review – ACR Preview Edition (10.19.18)

Save

Dr. Jack Cush summarizes the news and reports from RheumNow.Com this past week and previews RheumNow activities at the upcoming ACR 2018 meeting in Chicago.

It's the Genes, Not the Diet that Raises Urate

Save

Researchers from New Zealand find that in contrast with genetic contributions, diet explains very little variation in serum urate levels in the general population.

Update on Immune Checkpoint Inhibitor Toxicity

Save

JAMA has a 2018 update/review of the safety issues seen with mmune checkpoint inhibitors (ICIs) - important new cancer therapies, with 14 cancer indications, that have significantly improved survival in several. ICIs are monoclonal antibodies that block inhibitors of T-cell activation and function.